ICMJE Form for Disclosure of Potential Conflicts of Interest

Similar documents
ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Uniform Disclosure Form for Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

INTERNATIONAL COMMITTEE 9/ MEDICAL [OURNAL EDITORS

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

All authors of papers submitted to (name of journal) must complete this form and disclose any real or perceived conflict of interest.

IeMJE~iA~~1~1 J~~~~tl'~g;;'g'~

Financial Conflicts of Interest in Research: Putting the Pieces Together

UA Policy on Conflict of Interest/Financial Disclosure in Research and Other Sponsored Programs (revised August 2012) FREQUENTLY ASKED QUESTIONS

UC Davis Policy and Procedure Manual

Letter of Intent to Establish a Consortium Agreement Saint Louis University as Primary Applicant

Conflict of Interest Management Plan. You disclosed one or more significant financial interest(s) related to your university responsibilities.

Please scroll through and complete the entire form! Your application will not be accepted if all areas highlighted in yellow are not complete.

Investigator s Disclosure of Economic Interests Addendum

Florida International University Herbert Wertheim College of Medicine Industry Relations Policy and Guidelines 2/16/15

Conflict of Interest with Grants Policy DRAFT

RESEARCH CONFLICT OF INTEREST. Vyju Ram, MD Conflict of Interest Program

Financial Conflict of Interest Promoting Objectivity in Research Policy

MARICOPA COUNTY COMMUNITY COLLEGE DISTRICT STANDARDS FOR FINANCIAL DISCLOSURE TO AVOID CONFLICT OF INTEREST IN FEDERALLY-FUNDED PROJECTS

XAVIER UNIVERSITY. Financial Conflict of Interest Policy-Federal Grant Proposals

Section 1 Conflicts of Interest Introduction

CALIFORNIA STATE UNIVERSITY LOS ANGELES. for PROJECTS FUNDED BY THE PUBLIC HEALTH SERVICE (PHS)

1. Employment, Consulting, Product Development (Design Team/Royalty-based Contracts) and Research Arrangements with a Commercial Orthopaedic Company

FINANCIAL CONFLICT OF INTEREST POLICY Public Health Services SECTION 1 OVERVIEW, APPLICABILITY AND RESPONSIBILITIES

POLICY: Conflict of Interest

Approved by: UMMG Executive Committee. Date Approved: NOVEMBER 22, 2011

Intellectual Property Policy: Purpose. Applicability. Definitions

UTAH VALLEY UNIVERSITY Policies and Procedures

ALLEGHENY GENERAL HOSPITAL Pittsburgh, Pennsylvania

Grant Administration Glossary of Commonly-Used Terms in Sponsored Programs

2014 Breast Cancer Symposium September 4 6, 2014 San Francisco, CA

Your role in the CME Activity: Presenter Author Planning Committee Moderator Program Director. Title of CME Activity: Activity Date:

Financial Conflict of Interest Training

American Head & Neck Society

SEATTLE CHILDREN S RESEARCH INSTITUTE OPERATING POLICIES / PROCEDURES

2 nd Annual MedStar Washington Hospital Center Nursing Evidence-Based-Practice & Research Conference

GUIDELINES FOR INTERACTIONS OF CLINICIANS AND RESEARCHERS WITH INDUSTRY

ecoi Fast Start Guide

NAMI Illinois 2010 Annual Conference

Two Submission Dates. January 4, 2018 June 28, 2018

Educational Grant Application

UMass Memorial Medical Center Policy 1143 Vendor Relationships

Request to Use an External IRB as an IRB of Record

Dear Prospective Presenter:

Authorized licensed use limited to: UNIVERSITA MODENA. Downloaded on November 10,2011 at 14:46:47 UTC from IEEE Xplore. Restrictions apply.

9 th National Conference on Cancer Nursing Research February 8 10, 2007 Hollywood, California. General Information

NOVA SOUTHEASTERN UNIVERSITY OFFICE OF SPONSORED PROGRAMS POLICIES AND PROCEDURES

Conflict of Interest/Commitment

27th Annual Holiday Knee and Hip Course December 3-5, 2015 The Grand Hyatt New York City, NY

ACCME Data Request Form 792_ Page 1 of 8

> TITLE 13. LAW AND PUBLIC SAFETY

Standard Operating Procedures for P209: Investigator Conflict of Interest Policy

Financial Conflict of Interest Policy

If there are any unanswered (Required) questions by the deadline, your LOI will be disqualified and rejected from the Challenge.

Collaborative Operations and Services Grant Program GUIDELINES Revised January 15, 2014

Conflict of Interest Policy Texas Lutheran University

Charles A. King Trust Postdoctoral Research Fellowship Program

Investigator Conflict of Interest Disclosure Policy for Human Subjects Research

TRIOLOGICAL SOCIETY AUTHOR FORM

CALL FOR ABSTRACTS APHA CONTRIBUTED PAPERS PROGRAM. Visit to submit an abstract or obtain detailed program information

ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics. March 2018

European Respiratory Society Annual Declaration of Interest 2016

Children s Discovery Institute Grants Policies

Terms of Submission In order to participate, you must be at least eighteen (18) years old.

MSTS 2018 Abstract Submission Guidelines

University of Ottawa (uottawa) Terms & Non-Disclosure Agreement. for. Mitacs Accelerate Internships and. Mitacs Elevate Postdoctoral Fellowships

Physician/Industry Contacts: Updated Focus on CME & Grassley Looks at Possible Research Conflicts

SECTION PROPOSAL FOR EDUCATION ACTIVITY:

EMSC Emergency Medical Services Corporation EMSC Policies and Procedures Charitable Contribution Policy Policy No 203

FREQUENTLY ASKED QUESTIONS

ISOLS/MSTS 2015 Abstract Submission Guidelines

LETTER OF AGREEMENT TERMS AND CONDITIONS OF DISCRETIONARY GRANT

Call for Posters. Deadline for Submissions: May 15, Washington, DC Gaylord National Harbor Hotel October 18 21, 2015

Research and Development (R&D) tax credit

CME Policies & Procedures

LETTER OF INTENT INSTRUCTIONS

CANCER COUNCIL NSW PROGRAM GRANTS PEER REVIEW GUIDELINES

Call for Posters. Kansas City, Missouri October 21-24, Deadline for Submissions: June 20, 2018

Guiding Principle... 2

education continuing CARRELL-KRUSEN NEUROMUSCULAR SYMPOSIUM 33 rd ANNUAL Thursday-Friday, February 17-18, 2011

MEMBERSHIP AGREEMENT FOR THE ANALYTIC TECHNOLOGY INDUSTRY ROUNDTABLE

Damon Runyon-Sohn Pediatric Cancer Fellowship Award Award Statement

City of Colville Vinson Fund Application

Ohio Opioid Technology Challenge Idea Phase

St. Elizabeth Healthcare- Financial Assistance Policy

Professional Practices Policy (P3)

Regulations of Florida A&M University

DESIGN COMPETITION GUIDELINES

Code on Interactions with Healthcare. Professionals

Transcription:

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. 1. 2. 3. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. 4. 5. Intellectual Property. This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties. Relationships not covered above. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Definitions. Entity: government agency, foundation, commercial sponsor, academic institution, etc. Grant: A grant from an entity, generally [but not always] paid to your organization Personal Fees: Monies paid to you for services rendered, generally honoraria, royalties, or fees for consulting, lectures, speakers bureaus, expert testimony, employment, or other affiliations Non-Financial Support: Examples include drugs/equipment supplied by the entity, travel paid by the entity, writing assistance, administrative support, etc. Other: Anything not covered under the previous three boxes Pending: The patent has been filed but not issued Issued: The patent has been issued by the agency Licensed: The patent has been licensed to an entity, whether earning royalties or not Royalties: Funds are coming in to you or your institution due to your patent 1

Section 1. Identifying Information 1. Given Name (First Name) Michael 2. Surname (Last Name) 3. Date 07-December-2016 4. Are you the corresponding author? Yes No 5. Manuscript Title Orthopaedic Tips: The Mangled Extremity 6. Manuscript Identifying Number (if you know it) Section 2. The Work Under Consideration for Publication Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc.)? Are there any relevant conflicts of interest? Yes No Section 3. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication. Are there any relevant conflicts of interest? Yes No Section 4. Intellectual Property -- Patents & Copyrights Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes No 2

Section 5. Relationships not covered above Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Yes, the following relationships/conditions/circumstances are present (explain below): No other relationships/conditions/circumstances that present a potential conflict of interest At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Section 6. Disclosure Statement Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box below. Mr. has nothing to disclose. Evaluation and Feedback Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form. 3

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. 1. 2. 3. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. 4. 5. Intellectual Property. This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties. Relationships not covered above. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Definitions. Entity: government agency, foundation, commercial sponsor, academic institution, etc. Grant: A grant from an entity, generally [but not always] paid to your organization Personal Fees: Monies paid to you for services rendered, generally honoraria, royalties, or fees for consulting, lectures, speakers bureaus, expert testimony, employment, or other affiliations Non-Financial Support: Examples include drugs/equipment supplied by the entity, travel paid by the entity, writing assistance, administrative support, etc. Other: Anything not covered under the previous three boxes Pending: The patent has been filed but not issued Issued: The patent has been issued by the agency Licensed: The patent has been licensed to an entity, whether earning royalties or not Royalties: Funds are coming in to you or your institution due to your patent 1

Section 1. Identifying Information 1. Given Name (First Name) John 2. Surname (Last Name) 3. Date 07-December-2016 4. Are you the corresponding author? Yes No Corresponding Author s Name Michael 5. Manuscript Title Orthopaedic Tips: The Mangled Extremity 6. Manuscript Identifying Number (if you know it) Section 2. The Work Under Consideration for Publication Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc.)? Are there any relevant conflicts of interest? Yes No Section 3. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication. Are there any relevant conflicts of interest? Yes No If yes, please fill out the appropriate information below. Name of Entity Grant? Personal Fees? Non-Financial Support? Other? Comments Arthrex Consulting Section 4. Intellectual Property -- Patents & Copyrights Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes No 2

Section 5. Relationships not covered above Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Yes, the following relationships/conditions/circumstances are present (explain below): No other relationships/conditions/circumstances that present a potential conflict of interest At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Section 6. Disclosure Statement Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box below. Dr. reports personal fees from Arthrex Consulting, outside the submitted work;. Evaluation and Feedback Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form. 3